PRCT News and Press, PROCEPT BioRobotics Corporation From 09/19/22

Surgical robotics firm PROCEPT BioRobotics ( NASDAQ: PRCT ) and Providence announced on Monday a multi-system, national contract to acquire AquaBeam Robotic Systems. The company through the acquisition hopes to partner with health systems, such as Providence to support th...

REDWOOD CITY, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, and Providence, a not-for-profit health system serving the...

Summary Halvorsen's 13F portfolio value decreased from $24.74B to $21.86B this quarter. The number of positions increased from 56 to 82. Viking Global added McKesson, American International Group, and Intuit while decreasing T-Mobile US, General Electric, and Brookfield Asset Mana...

Summary Two new Breakout Stocks for Week 36 with better than 10% short-term upside potential and a Dow 30 pick. Average cumulative returns now down to +106.5% YTD. This week no picks beat 10% gains in less than a week with only small gains before the gauges turned much more negati...

Summary Procept BioRobotics went public in September 2021, raising approximately $164 million in an IPO. The firm is commercializing a water-based ablation device to treat benign prostatic hyperplasia, a common condition in older men. PRCT is ramping up commercialization of it...

REDWOOD CITY, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present and host...

PROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Conference Call August 4, 2022 4:30 P.M. ET Company Participants Matt Bacso - Investor Relations Reza Zadno - Chief Executive Officer Kevin Waters - Chief Financial Officer Conference Call Participants...

Image source: The Motley Fool. PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Q2 2022 Earnings Call Aug 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: PROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Cal...

Procept press release ( NASDAQ: PRCT ): Q2 net income of -$19.2M (vs. -$14.6M Y/Y) Revenue of $16.7M (+97% Y/Y) beats by $2.21M . FY22 revenue guidance in range of $66M to $68M (vs. consensus of $61.57M) Shares +0.65% . For further details see: Pr...

REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited fina...